NASDAQ
Beta Bionics, Inc. (BBNX)
♥ 621 Thanks from members
Beta Bionics (BBNX) displays a tension between strong 57% YoY revenue growth, improved gross margins, and a $240M cash buffer, versus escalating operating expenses, legal/regulatory investigations, and fierce competition.